Concepedia

Maher Albitar

MA

251

Publications

25.1K

Citations

76

H-Index

1989

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Quest Diagnostics (United States)

NeoGenomics (United States)

The University of Texas Health Science Center at San Antonio

Maher Albitar is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and hematology.

ORCID

Top concepts

Publications per year

1989–2020

251

Publications

251

Decitabine improves patient outcomes in myelodysplastic syndromes

Hagop M. Kantarjian, Jean‐Pierre J. Issa, C Rosenfeld et al. · Cancer · 2006 · 1.5K citations

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

Hagop M. Kantarjian, Francis J. Giles, Lydia Wunderle et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

Sergio Giralt, Elihu H. Estey, Maher Albitar et al. · Blood · 1997 · 1.2K citations · Full text

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Michael J. Keating, Susan O’Brien, Maher Albitar et al. · Journal of Clinical Oncology · 2005 · 947 citations · Full text

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

Michael J. Keating, Ian W. Flinn, Vinay Jain et al. · Blood · 2002 · 946 citations · Full text

Rows per page

1–5 of 251